selected publications academic article Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice. Oncotarget. 1737-1748. 2021 Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLoS One. e0215584. 2019 Stability and Mobility of Magnetic Nanoparticles in Biological Environments Determined From Dynamic Magnetic Susceptibility Measurements. Bioconjugate Chemistry. 29:2793-2805. 2018 Cathepsin L Inactivation Leads to Multimodal Inhibition of Prostate Cancer Cell Dissemination in a Preclinical Bone Metastasis Model. International Journal of Cancer. 138:2665-2677. 2016 Cathepsin L Inactivation Leads to Multimodal Inhibition of Prostate Cancer Cell Dissemination in a Preclinical Bone Metastasis Model. International Journal of Cancer. 138:2665-2677. 2016 Combining Tyrosine Kinase Inhibitors and Isoflavones To Target Metastatic Activity in Prostate Cancer Cells. Cancer Research. 74. 2014-10-01 Mri-Based Computational Model of Heterogeneous Tracer Transport Following Local Infusion Into a Mouse Hind Limb Tumor. PLoS One. 9. 2014-03-01 Transcriptional Repression of Vegf By Znf24: Mechanistic Studies and Vascular Consequences in Vivo. Blood. 121:707-715. 2013-01-01 Impact of the Src Inhibitor Dasatinib On the Metastatic Phenotype of Human Prostate Cancer Cells. Clinical & Experimental Metastasis. 29:133-142. 2012-02-01 Support of a Free Radical Mechanism for Enhanced Antitumor Efficacy of the Microtubule Disruptor Oxi4503. Microvascular research MVR. 81:44-51. 2011-01-01 Impact of the Src Inhibitor Saracatinib On the Metastatic Phenotype of a Fibrosarcoma (Kht) Tumor Model. Anticancer Research. 30:4405-4413. 2010-11-01 Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.. Journal of Nutrition. 137. 2007 Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate. 2002
principal investigator on Impact of Soy Isoflavones on Prostate Cancer awarded by United Soybean Board 2012 - 2014
co-principal investigator on Antioxidant Interactions With Prostate Cancer Treatments awarded by National Institutes of Health 2006 - 2010